Health Catalyst, Inc. (HCAT)

Kritische 8-K Meldungen

WARNUNG: Kritische 8-K-Meldung(en)
HOCH Abgang Schlüsselpersonen (27.04.2026)

Datum	Meldung	Schwere	Filing	Auszug
27.04.2026	Item 5.02 — Abgang Schlüsselpersonen	HOCH	SEC	n 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment

Stammdaten

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accuracy; population health management identifies improvement across the care continuum as well as actionable guidance for success and automated workflows; financial transformation providing costing and labor productivity insights and revenue capture; quality and safety improvement using clinical quality and patient safety data, analytics, and expert services; and national data ecosystem for thought leadership and mutual knowledge exchange to transform care delivery through next-gen insights. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is based in South Jordan, Utah.

Unternehmen & Branche

Name	Health Catalyst, Inc.
Ticker	HCAT
CIK	0001636422
Boerse	US
Sektor	Healthcare
Industrie	Medical - Healthcare Information Services
SIC	7370 · Services-Computer Programming, Data Processing, Etc.

Wertpapier & Kennzahlen

CUSIP	–
ISIN	–
Typ	Common Stock
Marktkapitalisierung	97,1 Mio. USD
Beta	1,82
Dividendenrendite	0,00 %

Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »

Finanzkennzahlen (SEC XBRL)

Periode	Filing	Umsatz	Nettoergebnis	EPS	Aktiva	Eigenkapital
2025-12-31	10-K	311,136,000	-177,974,000	-2.55	502,643,000	245,780,000
2025-09-30	10-Q	76,323,000	-22,229,000	-0.32	587,128,000	331,923,000
2025-06-30	10-Q	80,721,000	-40,978,000	-0.59	616,180,000	347,547,000
2025-03-31	10-Q	79,413,000	-23,742,000	-0.35	891,542,000	376,811,000
2024-12-31	10-K	306,584,000	-69,502,000	-1.15	858,929,000	365,207,000
2024-09-30	10-Q	76,353,000	-14,726,000	-0.24	813,050,000	355,037,000
2024-06-30	10-Q	75,902,000	-13,516,000	-0.23	691,720,000	357,002,000
2024-03-31	10-Q	74,723,000	-20,587,000	-0.35	695,112,000	357,210,000
2023-12-31	10-K	295,938,000	-118,147,000	-2.09	701,814,000	366,919,000
2023-09-30	10-Q	73,773,000	-22,032,000	-0.39	712,920,000	382,394,000
2023-06-30	10-Q	73,213,000	-32,613,000	-0.58	722,903,000	389,867,000
2023-03-31	10-Q	73,868,000	-33,190,000	-0.60	752,301,000	405,146,000
2022-12-31	10-K	276,236,000	-137,403,000	-2.63	752,286,000	425,010,000
2022-09-30	10-Q	68,354,000	-45,735,000	-0.84	776,200,000	439,966,000
2022-06-30	10-Q	70,633,000	-33,428,000	-0.62	811,339,000	469,055,000
2022-03-31	10-Q	68,087,000	-22,458,000	-0.54	824,919,000	480,909,000
2021-12-31	10-K	241,926,000	-153,210,000	-3.23	832,096,000	522,098,000
2021-09-30	10-Q	61,737,000	-40,014,000	-0.82	845,513,000	549,206,000
2021-06-30	10-Q	59,627,000	-35,834,000	-0.80	562,956,000	275,904,000
2021-03-31	10-Q	55,846,000	-28,370,000	-0.65	571,219,000	268,836,000

Fondsaktivität (Vorquartalsvergleich)

Keine Fondsdaten für dieses Unternehmen vorhanden.

Insider-Transaktionen (12 Monate)

Datum	Insider	Rolle	Typ	Stückzahl	Kurs	Wert (USD)	Δ	Trend
2025-12-05	Landry Benjamin	Officer, General Counsel	Open Market Sale	-27,425	2.64	-72,327.95	-72,1%
2025-12-04	Larson-Green Julie	Director	Open Market Sale	-47,997	2.67	-128,348.78	-127,9%

Top-Fondshalter

Keine Fondsdaten zu dieser Aktie vorhanden.